BBNX
Beta BiOct reports Q3 2026 results, raises cash
Beta Bionics reported Q3 2026 results showing significant sales growth and operating losses; it provided fresh full-year guidance and completed a $161M equity offering.
BBNX news
Latest 3 stories · newest Oct 27, 2026
BBNX
Beta Bionics announces FDA clearance for Mint patch pump and algorithm
Beta Bionics receives FDA clearance for its new Mint patch pump and submitted the 3D Intelligence algorithm, shifting its commercialization timeline to 2026 and 2027 respectively while increasing manufacturing expectations for the new device.
BBNX
Beta Bionics updates Mint patch pump commercialization timeline to Q2 2027
Beta Bionics announced it expects to fully commercialize its Mint patch pump by the end of Q2 2027, subject to FDA regulatory clearance, based on positive FDA responses and manufacturing scaling progress. The product aims to expand insulin pump options for diabetes patients by offering a smaller for…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same BBNX feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/BBNX/newsSTART FREE